维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Uharek"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Thl- and Th2-type CD4(+)T cells in mice显示文摘	Uharek L Hartung G	2001	Hematol J2001，2，：	1
2	High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2显示文摘	Uharek L Zeis M Glass B	1996	Leukemia1996，10，：	1
3	Graft-vs-leukemia activity and graft-vs-lost disease induced by allogeneic Th1-and Th2-type CD4^+ T cell in mice显示文摘	Zeis M Uharek L Hartung G	2001	Hematol J2001，2，2：	1
4	High lytic,activity,against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2显示文摘	Uharek L Zeis M Glass B		0，，：	1
5	Genetically Modified T Cells for the Treatment of Malignant Disease显示文摘	Wieczorek A Uharek L	2013	Transfus Med Hemother2013，40，6：	1
6	Activation of natural killer cells with interleukin 2 (IL-2)and IL-12 increases perforin binding and subsequent lysis of tumour cells 显示文摘	Lehmann C Zeis M Uharek L	2001	Br J Haematol2001，114，3：	1
7	Aetivation of natural killer cell with Interleukin (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells显示文摘	Lehmann C Zeis M Uharek L	2001	Br J Heamatol2001，114，3：	1
8	Activation of natural killer cells with interleukin 2 (/L-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells 显示文摘	Lehmann C Zeis M Uharek L	2001	Br J Heamatol2001，114，3：	1
9	Graft-versus-leukaemia activity can be predicted by natural cytotoxity against leukemia cells显示文摘	Glass B Uharek L Zeis M	1996	Br J Haematol1996，93，2：	1
10	Induction of graft-versus-leukemi a(GVL) activity in murine leukemia models after I1-2 pretreatment of syngeneic and allogeneic bone marrow grafts显示文摘	Uharek L Glass B	1994	Bone Marrow Transplant1994，14，5：	1
11	Allogeneic MHC - mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft - versus - leukaemia effect in mice显示文摘	Uharek L Glass B	1997	Br J Haematol1997，96，4：	1
12	High lytic activity against human leukemia cells after actiration of allogeneic NK cells by IL-12 and lL-2显示文摘	Uharek L Zeis M Glass B	1996	Leukemia1996，10，：	1
13	Genetically Modified T Cells for the Treatment of Malignant Disease 显示文摘	Wieczorek A Uharek L	2013	Transfus Med Hemother2013，40，6：	1
14	Activation of natural killer cells with interleukin-2(IL-2) and IL-12 increases perforin binding and subsequent lysis of tumor cells显示文摘	Lehmann C Zeis M and Uharek	2001	Br J Haematol2001，114，3：	1
15	High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2显示文摘	Uharek L Zeis M Glass B	1996	Leukemia1996，10，：	1
16	Graft-vs-leukemia activity and graft-versus-host disease induced by allogeneic Th1-and Th2-type CD4+ T cells in mice 显示文摘	Zeis M Uharek L Hartung G	2001	Hematol J2001，2，2：	1
17	High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2显示文摘	UHAREK L ZEIS M GLASS B	1999	Leukemia1999，10，：	1
18	Graft-versus-leukemia activity can be predicted by natural cytotoxity against leukemia cells显示文摘	GLASS B UHAREK L ZEIS M	1996	Br J Haematol1996，93，2：	1
19	Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice显示文摘	Zeis M Uharek L Glass B	1997	Br J Haematol1997，96，4：	1
20	Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells显示文摘	Glass B Uharek L Zeis M	1996	Br J Haematol1996，93，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示